drugset / Trial / NCT00622986

China Cimicifuga Trial of Climacteric Complaint Control

NCT00622986 ↗

Phase 4 Unknown 288 enrolled Shandong Luye Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is designed to determine whether an extract of Cimicifuga Foetida L. is safe and efficacious to relieve the climacteric symptoms of Chinese women

Timeline

Start
2008-02
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Cimicifuga Foetida L. Unknown 2 unknown —

Indications

No indication recorded.